In this study, we showed that pristimerin suppressed tumor angiogenesis in NCI-H1299 xenografts via inhibiting Gli1 nucleus distribution in endothelial cells and pericytes, and then inactivating Shh/Gli1 and its downstream signaling pathway. This evidence concerns the gene SHH and neoplasm.